112 related articles for article (PubMed ID: 38368781)
1. The contribution of childhood maltreatment to the incidence of heavy cannabis use in Iran (IRNS-CCI): A multicenter, matched-pairs, nested, case-control study.
Pirnia B; Soleimani A; Farhoudian A; Zahiroddin A
Child Abuse Negl; 2024 Mar; 149():106632. PubMed ID: 38368781
[TBL] [Abstract][Full Text] [Related]
2. Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users.
Schwilke EW; Gullberg RG; Darwin WD; Chiang CN; Cadet JL; Gorelick DA; Pope HG; Huestis MA
Addiction; 2011 Mar; 106(3):499-506. PubMed ID: 21134021
[TBL] [Abstract][Full Text] [Related]
3. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
[TBL] [Abstract][Full Text] [Related]
4. Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.
Lowe RH; Abraham TT; Darwin WD; Herning R; Cadet JL; Huestis MA
Drug Alcohol Depend; 2009 Nov; 105(1-2):24-32. PubMed ID: 19631478
[TBL] [Abstract][Full Text] [Related]
5. An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses.
Hinckley JD; Saba L; Raymond K; Bartels K; Klawitter J; Christians U; Hopfer C
Cannabis Cannabinoid Res; 2022 Feb; 7(1):65-77. PubMed ID: 33998853
[No Abstract] [Full Text] [Related]
6. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
Di Forti M; Quattrone D; Freeman TP; Tripoli G; Gayer-Anderson C; Quigley H; Rodriguez V; Jongsma HE; Ferraro L; La Cascia C; La Barbera D; Tarricone I; Berardi D; Szöke A; Arango C; Tortelli A; Velthorst E; Bernardo M; Del-Ben CM; Menezes PR; Selten JP; Jones PB; Kirkbride JB; Rutten BP; de Haan L; Sham PC; van Os J; Lewis CM; Lynskey M; Morgan C; Murray RM;
Lancet Psychiatry; 2019 May; 6(5):427-436. PubMed ID: 30902669
[TBL] [Abstract][Full Text] [Related]
7. Occupational Exposure to Secondhand Cannabis Smoke Among Law Enforcement Officers Providing Security at Outdoor Concert Events.
Wiegand DM; Methner MM; Grimes GR; Couch JR; Wang L; Zhang L; Blount BC
Ann Work Expo Health; 2020 Aug; 64(7):705-714. PubMed ID: 32219297
[TBL] [Abstract][Full Text] [Related]
8. Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.
Karschner EL; Schwilke EW; Lowe RH; Darwin WD; Herning RI; Cadet JL; Huestis MA
J Anal Toxicol; 2009 Oct; 33(8):469-77. PubMed ID: 19874654
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults.
Schlienz NJ; Cone EJ; Herrmann ES; Lembeck NA; Mitchell JM; Bigelow GE; Flegel R; LoDico CP; Hayes ED; Vandrey R
J Anal Toxicol; 2018 May; 42(4):232-247. PubMed ID: 29300962
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a Delta-9-Tetrahydrocannabinol Carboxylic Acid (Δ9-THC-COOH) Immunoassay and a Gas Chromatography-Mass Spectrometry (GC-MS) Method for the Detection of Delta-8-Tetrahydrocannabinol Carboxylic Acid (Δ8-THC-COOH).
Baird SN; Frazee CC; Garg U
J Appl Lab Med; 2023 Jul; 8(4):665-673. PubMed ID: 37071885
[TBL] [Abstract][Full Text] [Related]
11. Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users.
Lewis J; Molnar A; Allsop D; Copeland J; Fu S
Int J Legal Med; 2016 Jan; 130(1):147-52. PubMed ID: 26233612
[TBL] [Abstract][Full Text] [Related]
12. Urinary clearance of 11-nor-9-carboxy-Δ
Sempio C; Huestis MA; Kaplan B; Klawitter J; Christians U; Henthorn TK
Drug Test Anal; 2022 Aug; 14(8):1368-1376. PubMed ID: 35332698
[TBL] [Abstract][Full Text] [Related]
13. Development of a quick preparation method for the analysis of 11-nor-9-carboxy-∆
Ishii A; Sato K; Kusakabe K; Kato N; Wada T
J Pharm Biomed Anal; 2023 Sep; 234():115556. PubMed ID: 37422956
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
Fraser AD; Worth D
Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
[TBL] [Abstract][Full Text] [Related]
15. THC and THC-COOH hair concentrations: Influence of age, gender, consumption habits, cosmetics treatment, and hair features.
Vaiano F; Scuffi L; Lachi A; Trignano C; Argo A; Mari F; Bertol E
J Pharm Biomed Anal; 2023 Feb; 225():115237. PubMed ID: 36638568
[TBL] [Abstract][Full Text] [Related]
16. Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?
Karschner EL; Schwilke EW; Lowe RH; Darwin WD; Pope HG; Herning R; Cadet JL; Huestis MA
Addiction; 2009 Dec; 104(12):2041-8. PubMed ID: 19804462
[TBL] [Abstract][Full Text] [Related]
17. 11-OH-THC in hair as marker of active cannabis consumption: Estimating a reliable cut-off by evaluation of 672 THC-positive hair samples.
Casati S; Angeli I; Ravelli A; Del Fabbro M; Minoli M; Orioli M
Forensic Sci Int; 2019 Nov; 304():109951. PubMed ID: 31563559
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of Cannabis Brownies: A Controlled Examination of Δ9-Tetrahydrocannabinol and Metabolites in Blood and Oral Fluid of Healthy Adult Males and Females.
Spindle TR; Cone EJ; Herrmann ES; Mitchell JM; Flegel R; LoDico C; Bigelow GE; Vandrey R
J Anal Toxicol; 2020 Oct; 44(7):661-671. PubMed ID: 32591782
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.
Nadulski T; Sporkert F; Schnelle M; Stadelmann AM; Roser P; Schefter T; Pragst F
J Anal Toxicol; 2005; 29(8):782-9. PubMed ID: 16356335
[TBL] [Abstract][Full Text] [Related]
20. Determination of Enzymatic Hydrolysis Efficiency in Detection of Cannabis Use by UPLC-MS-MS.
Kul A; Sagirli O
J Anal Toxicol; 2022 Mar; 46(3):257-263. PubMed ID: 33543758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
